undiagnosed obstructive sleep apnea (OSA). With up to 90% of sleep-related breathing disorders going undiagnosed, Vivos is pioneering a transformative approach with the Vivos Method—a patient ...

Vivos announces immediate expansion of its new alliance model into two additional Colorado locations as initial reports show sleep apnea patients prefer Vivos CARE treatment for OSA nearly 2 to 1 ...

obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of ...

Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leader in novel, non-invasive obstructive sleep apnea (OSA) treatments, today announced several significant milestone ...

Operator Greetings and welcome to the 3D Systems fourth quarter and fiscal year 2024 earnings conference call and webcast. At ...

Sleep apnea screenings will be free for New Yorkers under a new law passed Wednesday.

A researcher at Northeastern University has found a groundbreaking new way to diagnose people with sleep apnea that could ...

Among patients with OSA, sleep surgery vs CPAP therapy or no treatment reduces the risk for motor vehicle accidents.

Of those with sleep apnea, 5,284 people, or 3.4%, developed Parkinson's disease within five years, compared to 37,873 people, or 3.8% of those who did not have sleep apnea.